Preferred Name |
maralixibat |
Synonyms |
(4R,5R)-5-(4-((4-(4-aza-1-azoniabicyclo(2.2.2)octan-1-ylmethyl)phenyl)methoxy)phenyl)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6-benzothiepin-4-ol |
ID |
http://purl.bioontology.org/ontology/MESH/C000722912 |
altLabel |
(4R,5R)-5-(4-((4-(4-aza-1-azoniabicyclo(2.2.2)octan-1-ylmethyl)phenyl)methoxy)phenyl)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6-benzothiepin-4-ol livmarli |
cui |
C5418448 C5557855 |
HM |
D001582 |
Inverse of RB |
0 |
Mapped to | |
MDA |
20220722 |
MeSH Frequency |
0 |
MMR |
20220727 |
notation |
C000722912 |
prefLabel |
maralixibat |
SC |
1 |
SRC |
Drugs . 2022 Jan;82(1):71-76. |
TERMUI |
T001122811 T001122682 T001122810 |
TH |
NLM (2022) |
tui |
T109 T121 |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C170148 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |